 Home > Active Ingredient News > Drugs Articles > How fragrant is the black technology AI, look here, tens of billions of cooperation has appeared!

How fragrant is the black technology AI, look here, tens of billions of cooperation has appeared!

 Last Update: 2022-01-25
 Source: Internet
 Author: User

Tags

side effects lithium

acetylcysteine side effects

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The development of new drugs is a time-consuming and costly project with a high failure rate
.

According to estimates by the PhRMA (Manufacturers Association), developing a new drug in recent years takes about 10 years and costs an average of $2.

The transformation of artificial intelligence (AI) to medicine and life sciences is considered one of the most promising directions
.

In recent years, the application of AI in the field of medicine has flourished, and many companies around the world have reached cooperation in the development of new drugs based on AI, as shown in the table below
.

Looking at the above transactions, both large multinational pharmaceutical companies, domestic traditional pharmaceutical companies (such as Hengrui Medicine) and emerging pharmaceutical companies (such as Tianjing Bio and Hebo Pharmaceutical) are very optimistic about the potential of AI in new drug research and development.
AI players reach strategic cooperation
.

Moreover, some pharmaceutical companies have reached cooperation with multiple AI players.

In addition, two of the aforementioned transactions were very high in value
.

Among them, in December 2021, Roche and Generate Biomedicines reached a potential transaction value of more than 12 billion US dollars.

At present, the use of AI to develop new drugs has achieved initial results, and Exscientia has several candidate compounds that have entered the phase 1 clinical trial stage
.

Among them, the AI-designed compound DSP-1181 for the treatment of obsessive-compulsive disorder, in cooperation with Sumitomo Pharma, has started Phase 1 clinical trials in Japan in January 2020

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High purity Nicotinamide riboside chloride 98% with best price 23111-00-4 and Nicotinamide riboside chloride raw material

CAS No.: 23111-00-4

Pharmacy Grade

$8.8-10/MT FOB

Antistatic Agent Atmer 163 Cas 81646-13-1 99%

CAS No.: 81646-13-1

$2-2.2/MT EXW

Hydrolysis amino acid fertilizer amino acid powder organic fertilizer 80% light yellow powder AA80 shihong

CAS No.: 65072-01-7

Agricultural Grade

$2500-2600/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.